The 2026 European Aldosterone Conference meeting, co organized with INI-CRCT, will be held on October 16-17, 2026 in Kremlin-Bicêtre, near Paris, France, to provide the opportunity to meet and network with colleagues from Europe. The main topic of the meeting is to discuss novel indications and pharmacological approaches (e.g. recently approved non-steroidal MRA, aldosterone synthase inhibitors, incretins, SGLT2 inhibitors) for therapeutic targeting of the mineralocorticoid pathway or different sites of the RAAS. The meeting covers the full spectrum from basic science to clinical application.